Physician

Subil Go, MD

According to 2025 Medicare claims, Subil Go, MD (NPI: 1104043660) practices nephrology in the Yuba City, CA market, with the plurality of this provider's patient population coming from Yuba, CA. This provider's primary affiliated billing organization is NORTH VALLEY NEPHROLOGY INC (NPI: 1861567380; TIN: 20-3587827) and primary practice location at 95991-2971.

Go's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 734 traditional Medicare patients, billed 3,641 HCPCS/CPT codes, and received $305,329 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 2,716 prescription claims across 347 beneficiaries totaling $552,415 in drug costs, led by Jardiance (Empagliflozin). DME data shows 217 claims. Open Payments data shows 1 records totaling $88. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $1,408 to $177.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,025	4,380	$336,344
2016	786	3,703	$279,763
2017	792	3,826	$293,033
2018	805	4,281	$341,860
2019	853	4,400	$365,345
2020	775	3,983	$336,501
2021	775	3,496	$358,952
2022	760	3,229	$300,286
2023	740	3,117	$300,179
2024	734	3,641	$305,329

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	419	3,894	$561,455
2016	358	3,327	$571,004
2017	337	3,509	$581,456
2018	384	3,409	$512,857
2019	407	3,306	$515,793
2020	415	3,418	$491,065
2021	372	2,891	$422,003
2022	357	2,799	$540,367
2023	324	2,690	$535,916
2024	347	2,716	$552,415

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	235	$8,989
2016	N/R	223	$8,022
2017	N/R	305	$9,692
2018	N/R	284	$9,273
2019	N/R	197	$4,898
2020	N/R	286	$5,776
2021	N/R	375	$6,957
2022	N/R	372	$13,455
2023	N/R	254	$3,433
2024	N/R	217	$11,710

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	111	111	$118
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	207	318	$80
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	152	491	$62
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	342	434	$55
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	457	766	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	147	7,800	$144,335
Glyxambi	Empagliflozin/Linagliptin	40	2,460	$44,466
Procrit	Epoetin Alfa	39	1,080	$39,916
Kerendia	Finerenone	39	1,530	$30,816
Farxiga	Dapagliflozin Propanediol	30	1,740	$30,084

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7503	Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg	N	N/R	14	$9,198
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	43	$701
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	41	$696
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	60	$690
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	32	$251

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$88	Mallinckrodt Hospital Products Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Subil Go, MD?

Tedicare shows public-source Medicare data for Subil Go, MD (NPI 1104043660), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Subil Go, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Subil Go, MD?

Subil Go, MD is linked to NORTH VALLEY NEPHROLOGY INC (billing NPI 1861567380) in the available physician profile data.

Does Subil Go, MD have Open Payments data?

Subil Go, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.